Safety and efficacy of artemisinin-piperaquine for treatment of COVID-19: an open-label, non-randomised and controlled trial.
Li G, Yuan M, Li H, Deng C, Wang Q, Tang Y, Zhang H, Yu W, Xu Q, Zou Y, Yuan Y, Guo J, Jin C, Guan X, Xie F, Song J.
Li G, et al. Among authors: li h.
Int J Antimicrob Agents. 2021 Jan;57(1):106216. doi: 10.1016/j.ijantimicag.2020.106216. Epub 2020 Nov 2.
Int J Antimicrob Agents. 2021.
PMID: 33152450
Free PMC article.
Clinical Trial.